Investment Thesis
Sensus Healthcare is burning cash at an unsustainable rate with stagnant revenue growth (0% YoY), deteriorating profitability (-$2.6M net income, -216% YoY), and severe operating losses (-$4.4M on $3.4M revenue). While the strong cash position ($18.3M) provides a ~4-5 year runway, the company is destroying shareholder value with no clear path to profitability or operational cash flow sustainability.
Strengths
- Strong cash position of $18.3M with zero debt burden (Debt/Equity 0.0x)
- Excellent liquidity ratios (Current Ratio 7.27x, Quick Ratio 4.45x) provide financial flexibility
- Gross margin of 29.2% suggests underlying product viability at manufacturing level
Risks
- Severe and worsening profitability: -$2.6M net income with -216% YoY deterioration and -128.4% operating margin
- Negative operating cash flow of -$3.8M indicates core business is burning cash unsustainably
- Revenue stagnation at 0% YoY growth with massive operating expense structure relative to sales
- Large gap between gross margin (29.2%) and operating margin (-128.4%) reveals inefficient cost structure or commercialization challenges
- At current $3.8M annual burn rate, cash runway limited to 4-5 years without operational improvement
Key Metrics to Watch
- Operating cash flow trajectory and return to positive cash generation from operations
- Revenue growth acceleration and customer acquisition metrics
- Operating expense reduction to achieve positive operating income
- Cash runway sustainability and quarterly cash burn rate
Financial Metrics
Revenue
3.4M
Net Income
-2.6M
EPS (Diluted)
$-0.16
Free Cash Flow
-3.8M
Total Assets
51.5M
Cash
18.3M
Profitability Ratios
Gross Margin
29.2%
Operating Margin
-128.4%
Net Margin
-77.4%
ROE
-5.8%
ROA
-5.1%
FCF Margin
-110.7%
Balance Sheet & Liquidity
Current Ratio
7.27x
Quick Ratio
4.45x
Debt/Equity
0.00x
Debt/Assets
11.6%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-14T07:21:10.723498 |
Data as of: 2026-03-31 |
Powered by Claude AI